TickerTain
$SPCX····$NVDA····$MSFT····$GOOGL····$ANTHROPIC·$TSLA····$CRWV····$NBIS····$HIMS····$TSM····$ASML····$FIGURE·$LYFT····$UBER····$SNOW····$META····$ELEVENLABS·$CURSOR·$COGNITION·$OPENAI·$AAPL····$RKLB····$XAI·$AMZN····$AMD····$000660.KS····$INTC····
← newsroom
$VIRTA-HEALTH · Diabetes reversal platform positioned as pre-GLP-1 employer benefit heading to IPO
now playing · $VIRTA-HEALTH
$BFLY···bullish· high· pospablo
Handheld ultrasound IPO delivered strong returns despite interpretation bottleneck
Butterfly's phone-connected ultrasound democratizes imaging access for remote areas, and the fund realized a very good return at IPO; however, the remaining challenge is AI-assist…
$BB-SCRIPTSbearish· medium· pospablo
Maternity digital health point solution fails to scale for venture returns
After 9 years and several million in revenue, BB Scripts cannot scale beyond a ceiling, illustrating why point solutions in digital health generate insufficient IRR for venture po…
$VIRTA-HEALTHbullish· high· pospablo
Diabetes reversal platform positioned as pre-GLP-1 employer benefit heading to IPO
Virta's employer-paid program reverses type 2 diabetes without insulin, reducing costly complications; now positioned as a mandatory step before GLP-1 coverage, creating a massive…
$ADMIT-THERAPEUTICSneutral· medium· pospablo
Blood test predicts Alzheimer's and progression to dementia via beta-amyloid markers
Admit's blood-based assay detects beta-amyloid presence and predicts Alzheimer's progression to dementia, but commercial viability hinges on actionability — currently limited by l…
$INBRAIN-NEUROELECTRONICSbullish· high· posyolanda pérez
Graphene brain implants outperform Neuralink with human clinical validation
Inbrain's graphene-based neurostimulation devices achieve higher resolution than Neuralink, have already been implanted in humans for Parkinson's and epilepsy, and are led by ex-M…
$HIMS···bullish· mediumpablo
Integrated telehealth-pharmacy-marketing machine targeting multi-billion valuation
Hims & Hers operates a three-layer flywheel — teleconsultation, owned pharmacy fulfillment, and performance marketing — enabling end-to-end control of high-volume conditions like…
$KIDAbullish· medium· posjesús monleón
Home care platform becoming European category leader with €60M raised
Kida's trained caregiver marketplace has achieved product-market fit in Spain, attracting specialized health funds and Sabadell, and is profiling as the European winner in tech-en…
$COLUMBUS-VENTURE-PARTNERSneutral· lowpablo
Specialized fund with deep mRNA manufacturing expertise backing Viralgen exit
Columbus understands the mRNA production supply chain and backed Viralgen's €4B exit; their operational knowledge in manufacturing infrastructure makes them a key partner for hard…